Issue 39
04.04.2018
Business & Investment
- Israel exports intellectual property and expertise rather than cannabis.
- The Greek government is actively supporting a domestic cannabis industry.
- Canadian firms will have to wait as Germany stalls on licencing process.
- Is it worth investing in Israel’s medical cannabis industry?
- CBD products are becoming increasingly popular among millennials.
- Blue Moon is launching a THC-infused craft beer.
- Cannabis could become a vital source of renewable energy.
Note – Prohibition Partners will be attending ICBC Berlin next week.
Regulation & Politics
- Most Luxembourg residents want cannabis legalised for personal use.
- Harvard study shows liberal cannabis policies fuel economic innovation.
- Harsh cannabis policies in Belarus are being criticised by human rights activists.
- UK Home Office asked to consider cannabis treatment for five year old boy.
- A medical cannabis bill is advancing in South Korea.
Health & Science
- Cannabis can prevent dangerous drug use among at risk youths.
- Two new studies show how cannabis can help tackle the opioid epidemic.
- Cannabis for veterinary patients gets research funding.
- Preclinical study on antitumour effects of cannabis compounds shows positive results.
The European Cannabis Report
Cannabis Europa
Cannabis Europa, a conference dedicated to shaping the future of medical cannabis in Europe, will take place on 22nd May at the Barbican in London.
Last 2 weeks of early bird tickets – buy now
Market Focus
WHAT DOES THE FUTURE HOLD FOR THE CZECH CANNABIS INDUSTRY?
The Czech Republic has had a complex relationship with cannabis. With the attitudes towards legal cannabis changing throughout Europe, could the country gain a foothold in the emerging marketplace?